Lv2
160 积分 2025-03-28 加入
In Vitro Characterization of Five Humanized OKT3 Effector Function Variant Antibodies
6天前
已完结
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
6天前
已完结
An efficient route to human bispecific IgG
9天前
已完结
A review on toxicities of T-cell engager-based therapies in solid tumors
18天前
已关闭
Bispecific light T-cell engagers for gene-based immunotherapy of epidermal growth factor receptor (EGFR)-positive malignancies
23天前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
1个月前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
1个月前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
2个月前
已完结
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
2个月前
已完结
Process optimization of mRNA purification for vaccines and therapeutic applications
6个月前
已关闭
皖公网安备34019202002308
